A potentially life-threatening label mix-up prompted a recall of high blood pressure medication, said the U.S. Food and Drug Administration (FDA) on Aug. 27.
This recall is not linked to the massive FDA recall of medications containing valsartan, used for blood pressure and heart problems. A number of valsartan-containing drugs were recalled in July due to the presence of the substance NDMA, which has been linked to cancer.
